Related Experiment Video
Updated: May 20, 2026
11:17
Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
Published on: February 27, 2026
Early central airways lung cancer
Chiaki Endo1, Akira Sakurada, Takashi Kondo
1Department of Thoracic Surgery, Tohoku University Hospital, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Japan. endo@idac.tohoku.ac.jp
General Thoracic and Cardiovascular Surgery
|July 20, 2012
Summary
Early central airways lung cancer, though rare, is best detected using autofluorescence bronchoscopy. Photodynamic therapy or surgery offers good survival rates for this condition.
Area of Science:
- Pulmonology
- Oncology
- Medical Imaging
Background:
- Early central airways lung cancer represents a small fraction of all lung cancers.
- Prospective randomized trials are challenging due to low incidence.
- Retrospective studies provide valuable insights into this rare malignancy.
Purpose of the Study:
- To review diagnostic and treatment strategies for early central airways lung cancer.
- To highlight the efficacy of advanced bronchoscopic techniques.
- To discuss prognostic factors and treatment outcomes.
Main Methods:
- Literature review of diagnostic modalities including sputum cytology and bronchoscopy.
- Analysis of treatment outcomes for photodynamic therapy and surgical resection.
- Examination of the natural history and multicentricity of the disease.
Main Results:
- Autofluorescence bronchoscopy combined with white light bronchoscopy improves detection rates compared to white light alone.
- Photodynamic therapy is effective for tumors ≤10 mm, yielding high survival rates (5-year: ~80%, 10-year: ~70%).
- Surgical resection, including segmentectomy for function preservation, offers similar 5-year survival (~80%) for eligible patients.
Conclusions:
- Early central airways lung cancer requires specialized diagnostic approaches like advanced bronchoscopy.
- Photodynamic therapy and surgical resection are effective first-line treatments with good long-term survival.
- Management of subsequent primary lung cancers is crucial for overall patient prognosis.
Related Concept Videos
01:17Other Pulmonary Disorders
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: